{"code":1,"isDone":false,"toInsertArticleList":[{"createdTime":"2020-12-03 10:53:04","updatedTime":"2020-12-03 10:53:04","title":"“修复”人体葡萄糖传感器：播种糖尿病治疗的新希望！","link":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","description":"<div><div><div id=\"media\" class=\"rich_media_thumb_wrp\">\n\n            <img class=\"rich_media_thumb\" src=\"http://content.sov5.cn/mmbiz_jpg/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5Bl2Bz54uAEVJLTE3lMQars1EoicC160Golb7djklWKAJbuoTDnKDnNRlw?imageView2/1/w/600\">\n        </div>\n    \n\n    \n\n    <div class=\"rich_media_content\" id=\"js_content\">\n                    \n\n                    \n\n                    \n                    \n                    <section style=\"display:none;\" data-tools=\"新媒体管家\" data-label=\"powered by xmt.cn\"><br></section><section yne-bulb-block=\"paragraph\"><section style=\"text-align: center;margin-left: 8px;margin-right: 8px;\"><img class=\"rich_pages js_insertlocalimg\" data-ratio=\"0.3333333333333333\" data-s=\"300,640\" data-type=\"png\" data-w=\"900\" style=\"letter-spacing: 0.544px; max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyorS4PggDpXqpicD8J3D30x0qz8wxx0IxiaV6ddh7j6PABXqreL16wWiciaktlibvT60APRvH8Ob72XtplA/640?wx_fmt=png\"></section><section style=\"text-align: justify;margin-left: 8px;margin-right: 8px;\"><em style=\"max-width: 100%;color: rgb(136, 136, 136);font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal rgb border-box break-word><strong style=\"max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><span style=\"max-width: 100%;font-size: 14px;box-sizing: border-box !important;overflow-wrap: break-word !important;\">多扎格列艾汀单药或联合二甲双胍，带来了治疗糖尿病的希望之光。</span></strong></em></section><section style=\"max-width: 100%;min-height: 1em;margin-left: 8px;margin-right: 8px;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><br></section><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><br></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);\"><span style=\"font-family: 微软雅黑;\">因为</span><strong><span style=\"font-family: 微软雅黑;\">“发现葡萄糖激酶</span></strong></span><span style=\"font-size: 15px;color: rgb(136, 136, 136);font-family: 微软雅黑;\">（Glucokinase, GK）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);\"><strong><span style=\"font-family: 微软雅黑;\">作为血糖调节的传感器，感受葡萄糖浓度，调节胰腺中β细胞的胰岛素分泌水平</span></strong><strong><span style=\"font-family: 微软雅黑;\">，</span></strong><strong><span style=\"font-family: 微软雅黑;\"> <span style=\"font-family: 微软雅黑;\">以及</span></span></strong><strong><span style=\"font-family: 微软雅黑;\">参与进入</span></strong><strong><span style=\"font-family: 微软雅黑;\">III期</span></strong><strong><span style=\"font-family: 微软雅黑;\">研究的创新</span></strong><strong><span style=\"font-family: 微软雅黑;\">GKA</span></strong><strong><span style=\"font-family: 微软雅黑;\">*</span></strong><span style=\"font-family: 微软雅黑;\"><strong>研发的杰出成就“</strong>，2020年的内分泌学界<span style=\"font-family: 微软雅黑;\">的诺贝尔奖</span>Rolf Luft Award颁发给了宾夕法尼亚大学的Franz Matschinsky教授。<span style=\"font-family: 微软雅黑;\">这一大奖的获得，充分肯定了</span>Franz Matschinsky教授<span style=\"font-family: 微软雅黑;\">提出的关于</span>“</span><strong><span style=\"font-family: 微软雅黑;\">调</span></strong><strong><span style=\"font-family: 微软雅黑;\">控人类胰岛细胞和其他组织中的葡萄糖激酶</span></strong></span><span style=\"font-size: 15px;color: rgb(136, 136, 136);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">（</span>GK）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);\"><strong><span style=\"font-family: 微软雅黑;\">，可纠正2型糖尿病</span></strong><strong><span style=\"font-family: 微软雅黑;\">中的</span></strong><strong><span style=\"font-family: 微软雅黑;\">代谢缺陷</span></strong><span style=\"font-family: 微软雅黑;\">”<span style=\"font-family: 微软雅黑;\">的理论。</span></span></span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 14px;\"><em><span style=\"color: rgb(136, 136, 136);font-family: 微软雅黑;\">(*注：为华领医药的多扎格列艾汀Dorzagliatin）</span></em></span><span style=\"font-size: 15px;color: rgb(136, 136, 136);\"><em><span style=\"font-family: 微软雅黑;\"></span></em></span></p><section style=\"text-align: center;line-height: 1.75em;margin-left: 8px;margin-right: 8px;\"><br></section><section style=\"text-align: center;margin-left: 8px;margin-right: 8px;\"><img class=\"rich_pages\" data-ratio=\"0.665\" data-s=\"300,640\" data-type=\"png\" data-w=\"800\" style=\"max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5Blpw09CLangxEgy1VAKtFjrPS0lf58xOqU6zMCV7O7Bb6XZ7Dv13p1Hw/640?wx_fmt=png\"></section><p style=\"text-align: justify;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;color: rgb(136, 136, 136);font-size: 12px;\">瑞典卡罗琳斯卡医学院官方网站公布Franz Matschinsky教授获得Rolf Luft Award（点击查看大图）</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">基于上述理论的葡萄糖激酶激活剂</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（Glucokinase Activator, GKA）</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">诞生并曾在掀起全球研发的热潮。作为华领医药的高级科学顾问，Franz Matschinsky教授与华领医药一直共同探索葡萄糖激酶</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（GK）</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">在人体血糖稳态调控中所发挥的核心作用。华领医药在研的全球首创新药多扎格列艾汀</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">是目前唯一已进入且完成Ⅲ期临床研究的葡萄糖激酶激活剂</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（GKA）</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">，引来内分泌学术界的高度关注。就在刚刚结束的中华医学会糖尿病学分会第二十四次全国学术会议上，多位糖尿病领域大咖围绕葡萄糖激酶</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（GK）</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">的作用机制、多扎格列艾汀</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">临床研究进展进行了精彩分享。</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"text-align: center;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 17px;color: rgb(215, 0, 15);\"><strong><span style=\"font-family: 微软雅黑;\">葡萄糖激酶（</span></strong><strong><span style=\"font-family: 微软雅黑;\">GK）</span></strong><strong><span style=\"font-family: 微软雅黑;\">损伤：</span></strong></span></p><p style=\"text-align: center;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 17px;color: rgb(215, 0, 15);\"><strong><span style=\"font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">血糖失衡的重要</span>“推手</span></strong></span><span style=\"font-size: 15px;color: rgb(215, 0, 15);\"><strong><span style=\"font-family: 微软雅黑;\">”</span></strong></span></p><p style=\"text-align: center;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);\"><strong><span style=\"font-family: 微软雅黑;\"> </span></strong></span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">人体对葡萄糖的摄取和利用是一个复杂又精妙的过程，在这个过程中，一种独特的功能蛋白</span>——己糖激酶</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（HK）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">发挥着重要的作用。其中己糖激酶家族中唯一可以作为葡萄糖传感器的<span style=\"font-family: 微软雅黑;\">葡萄糖激酶</span></span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（GK）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">，又称己糖激酶</span>IV</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（HK-IV）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">——在人体血糖稳态调节中扮演关键角色<span style=\"font-family: 微软雅黑;\">。围绕葡萄糖激酶</span></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);\"><span style=\"font-family: 微软雅黑;\">在血糖稳态调节中的作用，</span><strong><span style=\"font-family: 微软雅黑;\">复旦大学附属中山医院李小英教授</span></strong><span style=\"font-family: 微软雅黑;\">的精彩论述徐徐展开。</span></span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">葡萄糖激酶</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">主<span style=\"font-family: 微软雅黑;\">要分布在胰岛、肝脏和肠道等部位，起着葡萄糖传感器的功能，其激活由葡萄糖浓度来决定，进而通过调节控糖激素，即胰岛素和胰高糖素的分泌，以及糖原合成，来维持葡萄糖稳态</span></span><span style=\"color: rgb(0, 0, 0);font-size: 12px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">1</span></sup></span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">。多个器官中的葡萄糖激酶</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">联手进行血糖调控：血糖过高时，胰岛</span>β细胞中葡萄糖激酶</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">活性增加，<span style=\"font-family: 微软雅黑;\">调节胰岛素适时适量的分泌；肝细胞中葡萄糖激酶</span></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">活性增加，促进肝糖原合成；同时α细胞中葡萄糖激酶</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">活性增强，抑制胰高糖素释放<span style=\"font-family: 微软雅黑;\">；<span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">反过来，血糖过低时，<span style=\"font-family: 微软雅黑;\">α细胞</span>中葡萄糖激酶</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">活性下降，启动胰高糖素及时分泌，使血糖上升至生理目标范围。</span>在肠道内</span>L细胞 中，随着葡萄糖水平增加，葡萄糖激酶</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">激活启动胰高糖素样肽-1</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GLP-1）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">分泌，GLP-1又可进一步促进β细胞的葡萄糖激酶</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">活性，同时促进胰岛素分泌增加。<span style=\"font-family: 微软雅黑;\">就是这样，葡萄糖激酶</span></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">作为葡萄糖传感器，将血糖水平控制在4~6.5mmol/L<span style=\"font-family: 微软雅黑;\">的目标区间内，维持人体的血糖稳态</span></span><span style=\"color: rgb(0, 0, 0);font-size: 12px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">2</span></sup></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（图1）</span><span style=\"color: rgb(0, 0, 0);font-size: 15px;font-family: 微软雅黑;\">。李小英教授作了个形象的比喻：这就<span style=\"font-family: 微软雅黑;\">类似于智能空调中传感器对温度的感知和传递功能，让智能空调设定一个舒适的温度范围。</span></span></p><p style=\"text-align: center;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><br></p><p style=\"text-align: justify;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><img class=\"rich_pages\" data-ratio=\"0.3844765342960289\" data-s=\"300,640\" data-type=\"png\" data-w=\"554\" style=\"max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5Bl1EctiaYIhW4JQ2JicKQjHGsPuLKpAyzAvocMP0lgH9OIWcwetqAog4Bg/640?wx_fmt=png\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\"> </span></p><p style=\"text-align: justify;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"color: rgb(136, 136, 136);font-size: 12px;font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">图</span>1：葡萄糖激酶（GK）在血糖重要调控器官发挥葡萄糖传感器的功能，调控和维持血糖稳态</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">葡萄糖激酶</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">在人体血糖稳态调控系统中起核心作用，其受损将导致葡萄糖稳态失衡</span>，<span style=\"font-family: 微软雅黑;\">是血糖升高的重要</span>“推手”。研究表明，T2DM患者胰岛和肝脏葡萄糖激酶</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\"> (GK) </span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">表达严重降低</span><span style=\"color: rgb(0, 0, 0);font-size: 12px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">3</span></sup><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">,4</span></sup></span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">，而且肝脏葡萄糖激酶</span><span style=\"color: rgb(136, 136, 136);font-family: 微软雅黑;\">（GK）</span>活性显著下降</span><span style=\"color: rgb(0, 0, 0);font-size: 12px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">5</span></sup><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">,6</span></sup></span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">，造成稳态调控系统对血糖变化的敏感性降低，因此血糖大幅波动，稳态失控。</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"text-align: center;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 17px;color: rgb(215, 0, 15);\"><strong><span style=\"font-family: 微软雅黑;\">“赋能”葡萄糖激酶（</span></strong><strong><span style=\"font-family: 微软雅黑;\">GK）</span></strong><strong><span style=\"font-family: 微软雅黑;\">：</span></strong></span></p><p style=\"text-align: center;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 17px;color: rgb(215, 0, 15);\"><strong><span style=\"font-family: 微软雅黑;\">播种恢复血糖稳态的希望</span></strong></span></p><p style=\"text-align: center;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);\"><strong><span style=\"font-family: 微软雅黑;\"> </span></strong></span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">葡萄糖激酶激活剂</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GKA）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">可与活性构象葡萄糖激酶</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">结合，<span style=\"font-family: 微软雅黑;\">血糖依赖性地调节葡萄糖激酶</span></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">返回到非活性构象<span style=\"font-family: 微软雅黑;\">，提高对葡萄糖的敏感性</span></span><span style=\"color: rgb(0, 0, 0);font-size: 12px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">7</span></sup></span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">。葡萄糖激酶</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">“赋能”后，就有了恢复血糖稳态的希望。</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);\"><strong><span style=\"font-family: 微软雅黑;\">南京大学医学院附属鼓楼医院朱大龙教授</span></strong><span style=\"font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">介绍说，全球目前有</span>5个<span style=\"font-family: 微软雅黑;\">葡萄糖激酶激活剂</span></span></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GKA）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">在研发过程中，其中华领医药<span style=\"font-family: 微软雅黑;\">多扎格列艾汀</span></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">是目前唯一已进入且完成</span>Ⅲ<span style=\"font-family: 微软雅黑;\">期临床研究的葡萄糖激酶激活剂</span></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GKA）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">。值得一提的是，多扎格列艾汀</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">是全球首创的葡萄糖激酶双重激活剂，化学结构独特，提高激酶催化效率，保持激酶葡萄糖浓度依赖，且能同时作用于胰岛和肝脏，修复</span>T2DM患者受损的葡萄糖传感器功能。同时，它的药代动力学参数优异，在5-200mg剂量区间，显示明确的剂量和血中暴露量线性关系，吸收代谢分布排泄性质支持与广泛的口服降糖药物联合使用，并没有种族差异</span><span style=\"color: rgb(0, 0, 0);font-size: 12px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">8</span></sup></span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">。</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">通过修复葡萄糖激酶</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">活性，<span style=\"font-family: 微软雅黑;\">多扎格列艾汀</span></span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">有提高对葡萄糖的敏感性，改善胰岛素早相分泌和肝脏葡萄糖的储备功能，重塑血糖稳态的潜力。基础研究显示，多扎格列艾汀</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">可提升糖尿病大鼠胰岛素分泌细胞数量至正常大鼠的</span>75%<span style=\"font-family: 微软雅黑;\">，提升其肝脏葡萄糖激酶</span></span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（GK）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">表达，恢复至正常表达量的80%</span><span style=\"color: rgb(0, 0, 0);font-size: 12px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">9</span></sup></span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">。在</span>Ⅰ期临床研究中，多扎格列艾汀</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">治疗</span>7天后，胰岛对血糖的敏感性<span style=\"font-family: 微软雅黑;\">即明显改善，</span>C肽分泌时相前移，胰岛素早相分泌得以改善</span><span style=\"color: rgb(0, 0, 0);font-size: 12px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">1</span></sup><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">0,11</span></sup></span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">。</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">Ⅱ<span style=\"font-family: 微软雅黑;\">期探索性研究显示，多扎格列艾汀</span></span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">治疗</span>12周，各剂量组<span style=\"font-family: 微软雅黑;\">血糖均持续下降，其中</span>75mg BID组<span style=\"font-family: 微软雅黑;\">糖化血红蛋白</span></span><span style=\"font-size: 15px;color: rgb(136, 136, 136);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">（</span>HbA</span><span style=\"color: rgb(136, 136, 136);font-size: 12px;\"><sub><span style=\"font-family: 微软雅黑;vertical-align: sub;\">1c</span></sub></span><span style=\"font-size: 15px;color: rgb(136, 136, 136);font-family: 微软雅黑;\">）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">相比基线降幅达</span>1.12%<span style=\"font-family: 微软雅黑;\">，显著优于安慰剂</span></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（图2）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">，餐后2小时血糖也较基线显著降低<span style=\"font-family: 微软雅黑;\">达</span>4.9mmol/L<span style=\"font-family: 微软雅黑;\">，同时，处置指数</span></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（DI）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">和</span>HOMA-IR评分显著改善<span style=\"font-family: 微软雅黑;\">，即使治疗结束后</span>1周<span style=\"font-family: 微软雅黑;\">，患者的</span>DI和HOMA-IR评分仍然显著改善，<span style=\"font-family: 微软雅黑;\">提示停药后疗效的持续性</span></span><span style=\"color: rgb(0, 0, 0);font-size: 12px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">1</span></sup><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">2</span></sup></span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">。而且，治疗期间没有发生药物相关的严重不良事件</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（SAE）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">或严重的低血糖事件</span><span style=\"color: rgb(0, 0, 0);font-size: 12px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">1</span></sup><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">2</span></sup></span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">，提示多扎格列艾汀</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">具有良好的耐受性和安全性。</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"text-align: justify;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><img class=\"rich_pages\" data-ratio=\"0.3862815884476534\" data-s=\"300,640\" data-type=\"png\" data-w=\"554\" style=\"max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlH3bibA8lljbCYwlTmQfZ8wQhZDuUl3Yt3ReKnJKP1O3b9RPSzulf7Pg/640?wx_fmt=png\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\"> </span></p><p style=\"text-align: justify;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 12px;color: rgb(136, 136, 136);\"><span style=\"font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">图</span>2：与安慰剂相比，Dorzagliatin 75mg BID治疗后HbA</span><sub><span style=\"font-family: 微软雅黑;vertical-align: sub;\">1c</span></sub><span style=\"font-family: 微软雅黑;\">降幅显著更优</span></span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">进入</span>Ⅲ期临床研究</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（播种研究，SEED）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">的多扎格列艾汀</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">，表现依然优秀。多中心、随机、双盲安慰剂对照的</span>SEED<span style=\"font-family: 微软雅黑;\">研究是全球首个</span>GKA<span style=\"font-family: 微软雅黑;\">，纳入</span>463<span style=\"font-family: 微软雅黑;\">例未使用糖尿病治疗药物的初治</span>2型糖尿病</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（T2DM）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">患者，以</span>2:1<span style=\"font-family: 微软雅黑;\">随机分配至多扎格列艾汀</span></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">组或安慰剂组治疗</span><span style=\"color: rgb(0, 0, 0);font-size: 12px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">1</span></sup><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">3</span></sup></span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">。研究显示：</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><br></span></p><section><section data-tools=\"新媒体排版\" data-id=\"3237528\" data-style-type=\"undefined\"><section style=\"border-width: 0px;border-style: none;border-color: initial;max-width: 100%;\"><section powered-by=\".us\" style=\"box-sizing: border-box;max-width: 100%;\"><section style=\"margin-top: 0.5em;margin-bottom: 0.5em;padding-left: 0.45em;box-sizing: border-box;max-width: 100%;\"><section style=\"padding: 5px;box-sizing: border-box;max-width: 100%;border-left: 2px solid rgb(204, 204, 204);\"><section powered-by=\".us\" style=\"box-sizing: border-box;max-width: 100%;\"><section style=\"box-sizing: border-box;max-width: 100%;\"><section style=\"box-sizing: border-box;max-width: 100%;\"><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">与安慰剂相比，多扎格列艾汀</span></strong></span><span style=\"color: rgb(136, 136, 136);font-size: 15px;font-family: 微软雅黑;\">（Dorzagliatin）</span><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">75mg BID单药治疗24周后<strong style=\"color: rgb(89, 87, 87);white-space: normal;\"><span style=\"font-family: 微软雅黑;\">HbA</span></strong></span></strong></span><span style=\"color: rgb(89, 87, 87);font-size: 12px;\"><strong><span style=\"font-family: 微软雅黑;\"><strong style=\"color: rgb(89, 87, 87);white-space: normal;\"><sub><span style=\"font-family: 微软雅黑;vertical-align: sub;\">1c</span></sub></strong></span></strong></span><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">相对基线降幅度显著更优</span></strong></span><span style=\"color: rgb(136, 136, 136);font-size: 15px;font-family: 微软雅黑;\">（-1.07%vs -0.5%, p&lt;0.0001）</span><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">，<strong style=\"color: rgb(89, 87, 87);white-space: normal;\"><span style=\"font-family: 微软雅黑;\">HbA</span></strong></span></strong></span><span style=\"color: rgb(89, 87, 87);font-size: 12px;\"><strong><span style=\"font-family: 微软雅黑;\"><strong style=\"color: rgb(89, 87, 87);white-space: normal;\"><sub><span style=\"font-family: 微软雅黑;vertical-align: sub;\">1c</span></sub></strong></span></strong></span><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">的血糖稳态达标率显著更高</span></strong></span><span style=\"color: rgb(136, 136, 136);font-size: 15px;font-family: 微软雅黑;\">（45% vs 21.5%, p&lt;0.0001）（图3）</span><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">；</span><br></strong></span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><br></p><section style=\"white-space: normal;\"><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">更显著改善β细胞功能</span></strong></span><span style=\"color: rgb(136, 136, 136);font-size: 15px;font-family: 微软雅黑;\">（HOMA2-β）（图4）</span><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">；</span></strong></span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\"><br></span></strong></span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">至治疗52周时，HbA</span></strong></span><span style=\"color: rgb(89, 87, 87);font-size: 12px;\"><strong><sub><span style=\"font-family: 微软雅黑;vertical-align: sub;\">1c</span></sub></strong></span><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">较基线下降1.11%</span></strong></span><span style=\"color: rgb(136, 136, 136);font-size: 15px;font-family: 微软雅黑;\">（p&lt;0.001）</span><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">， 疗效持续显著稳定</span></strong></span><span style=\"color: rgb(89, 87, 87);font-size: 12px;\"><sup style=\"\"><span style=\"font-family: 微软雅黑;vertical-align: super;\">13</span></sup></span><span style=\"color: rgb(89, 87, 87);\"><span style=\"font-size: 15px;font-family: 微软雅黑;\">，</span><strong><span style=\"font-size: 15px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\"> </span></sup></span></strong></span><span style=\"color: rgb(136, 136, 136);font-size: 15px;font-family: 微软雅黑;\">（图5）</span><span style=\"color: rgb(89, 87, 87);font-size: 12px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">13</span></sup></span><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">， 提示多扎格列艾汀</span></strong></span><span style=\"color: rgb(136, 136, 136);font-size: 15px;font-family: 微软雅黑;\">（Dorzagliatin）</span><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">单药长期治疗降糖效果仍持续稳定。</span></strong></span></p></section></section></section></section></section></section></section></section></section><p style=\"margin-right: 8px;margin-left: 8px;line-height: 1.75em;\"><br></p></section><p style=\"text-align: justify;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><img class=\"rich_pages\" data-ratio=\"0.48194945848375453\" data-s=\"300,640\" data-type=\"png\" data-w=\"554\" style=\"max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5Bl7khCodmvt9fmXRcialXibUIFNvPaJNHtzrDDicefRkezpcXic0QCcp7aog/640?wx_fmt=png\"></p><p style=\"text-align: justify;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 12px;color: rgb(136, 136, 136);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">图</span>3：与安慰剂相比，Dorzagliatin 75mg BID单药治疗HbA</span><span style=\"color: rgb(136, 136, 136);font-size: 12px;\"><sub><span style=\"font-family: 微软雅黑;vertical-align: sub;\">1c</span></sub></span><span style=\"font-size: 12px;color: rgb(136, 136, 136);font-family: 微软雅黑;\">降幅显著更优，血糖稳态达标率显著更高</span></p><p style=\"text-align: justify;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\"> </span></p><p style=\"text-align: justify;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><img class=\"rich_pages\" data-ratio=\"0.592057761732852\" data-s=\"300,640\" data-type=\"png\" data-w=\"554\" style=\"max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlPRvA3j8urjnfS4pZ97JtBjUwAibJjYQRH7jVxB9iaXn0QNkM25zbvLXw/640?wx_fmt=png\"></p><p style=\"text-align: justify;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"color: rgb(136, 136, 136);font-size: 12px;font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">图</span>4：与安慰剂相比，Dorzagliatin 75mg BID单药治疗显著<span style=\"font-family: 微软雅黑;\">改善</span>β细胞功能</span></p><p style=\"text-align: justify;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\"> </span></p><p style=\"text-align: justify;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><img class=\"rich_pages\" data-ratio=\"0.48014440433212996\" data-s=\"300,640\" data-type=\"png\" data-w=\"554\" style=\"max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlmXx4kJFWxKEj04RKa8S6EKptNH2icfngcWhwS7rHBiaeD2JOKCWXsIiaQ/640?wx_fmt=png\"></p><p style=\"text-align: justify;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"color: rgb(136, 136, 136);font-size: 12px;font-family: 微软雅黑;\">图5：多扎格列艾汀(Dorzagliatin)单药长期52周治疗降糖效果仍持续稳定</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">在特殊人群的用药方面，朱大龙教授介绍了在肾功能损伤患者中的药物代谢动力学研究。该研究发现，Dorzagliatin可以用于患有慢性肾脏病各个阶段的T2DM患者且无需调整剂量。</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"text-align: center;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 17px;color: rgb(215, 0, 15);\"><strong><span style=\"font-family: 微软雅黑;\">迎来黎明之光：</span></strong></span></p><p style=\"text-align: center;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 17px;color: rgb(215, 0, 15);\"><strong><span style=\"font-family: 微软雅黑;\">行进在希望的田野上</span></strong></span></p><p style=\"text-align: center;margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);\"><strong><span style=\"font-family: 微软雅黑;\"> </span></strong></span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">2019<span style=\"font-family: 微软雅黑;\">年发表在</span><em>Diabetes care</em>杂志的一项研究表明，积极治疗期间改血糖的降糖药物，包括二甲双胍GLP-1激动剂、甘精胰岛素，在停药后未能产生持久的益处</span><span style=\"color: rgb(0, 0, 0);font-size: 12px;\"><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">1</span></sup><sup><span style=\"font-family: 微软雅黑;vertical-align: super;\">4</span></sup></span><span style=\"font-size: 15px;color: rgb(0, 0, 0);\"><span style=\"font-family: 微软雅黑;\">，因此现有降糖药物尚未解决糖尿病的根本原因，该何去何从？</span><strong><span style=\"font-family: 微软雅黑;\">中日友好医院杨文英教授</span></strong><span style=\"font-family: 微软雅黑;\">认为，葡萄糖激酶</span></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">是血糖稳态的核心</span>“元件”<span style=\"font-family: 微软雅黑;\">，需要恢复这个葡萄糖传感器功能，才能进一步优化血糖管理效果。</span></span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">多扎格列艾汀</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">可作用在血糖调控的核心器官</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（胰岛和肝脏）</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">，旨在治标治本，恢复血糖调控的生理机制。Ⅲ期临床研究DAWN研究</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（黎明研究）</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">是多中心、随机、双盲安慰剂对照研究，纳入766例二甲双胍单药治疗不佳的T2DM患者，以1:1随机分配至多扎格列艾汀</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">或安慰剂组治疗双盲治疗24周以及开放标签治疗28周。</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">研究结果显示：</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\"><br></span></p><section><section data-tools=\"新媒体排版\" data-id=\"3237528\" data-style-type=\"undefined\"><section style=\"border-width: 0px;border-style: none;border-color: initial;max-width: 100%;\"><section powered-by=\".us\" style=\"box-sizing: border-box;max-width: 100%;\"><section style=\"margin-top: 0.5em;margin-bottom: 0.5em;padding-left: 0.45em;box-sizing: border-box;max-width: 100%;\"><section style=\"padding: 5px;box-sizing: border-box;max-width: 100%;border-left: 2px solid rgb(204, 204, 204);\"><section powered-by=\".us\" style=\"box-sizing: border-box;max-width: 100%;\"><section style=\"box-sizing: border-box;max-width: 100%;\"><section style=\"box-sizing: border-box;max-width: 100%;\"><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><strong><span style=\"color: rgb(89, 87, 87);font-size: 15px;font-family: 微软雅黑;\">与安慰剂相比，多扎格列艾汀</span></strong><span style=\"color: rgb(89, 87, 87);font-size: 15px;font-family: 微软雅黑;\">（Dorzagliatin）</span><strong><span style=\"color: rgb(89, 87, 87);font-size: 15px;font-family: 微软雅黑;\">与二甲双胍联合治疗<strong style=\"color: rgb(89, 87, 87);white-space: normal;\"><span style=\"font-family: 微软雅黑;\"><strong>HbA</strong></span></strong></span></strong><span style=\"font-size: 12px;\"><strong><span style=\"color: rgb(89, 87, 87);font-family: 微软雅黑;\"><strong style=\"color: rgb(89, 87, 87);white-space: normal;\"><span style=\"font-family: 微软雅黑;\"><strong><sub><span style=\"vertical-align: sub;\">1c</span></sub></strong></span></strong></span></strong></span><strong><span style=\"color: rgb(89, 87, 87);font-size: 15px;font-family: 微软雅黑;\">较基线降幅显著更优</span></strong><span style=\"color: rgb(136, 136, 136);font-size: 15px;font-family: 微软雅黑;\">（-1.02％ vs 0.36％，p&lt;0.0001)（图6）</span><strong><span style=\"color: rgb(89, 87, 87);font-size: 15px;font-family: 微软雅黑;\">，<strong style=\"color: rgb(89, 87, 87);white-space: normal;\"><span style=\"font-family: 微软雅黑;\"><strong>HbA</strong></span></strong></span></strong><span style=\"font-size: 12px;\"><strong><span style=\"color: rgb(89, 87, 87);font-family: 微软雅黑;\"><strong style=\"color: rgb(89, 87, 87);white-space: normal;\"><span style=\"font-family: 微软雅黑;\"><strong><sub><span style=\"vertical-align: sub;\">1c</span></sub></strong></span></strong></span></strong></span><strong><span style=\"color: rgb(89, 87, 87);font-size: 15px;font-family: 微软雅黑;\">达标率显著更高</span></strong><span style=\"color: rgb(136, 136, 136);font-size: 15px;font-family: 微软雅黑;\">（44.4% vs 10.7% p＜0.0001）（图7）</span><strong><span style=\"color: rgb(89, 87, 87);font-size: 15px;font-family: 微软雅黑;\">；</span></strong></p><section style=\"white-space: normal;\"><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><br></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><strong><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(89, 87, 87);\">空腹血糖显著降低更多</span></strong><span style=\"color: rgb(136, 136, 136);font-family: 微软雅黑;font-size: 15px;\">（-0.67mmol/L vs -0.29mmol/L, , p=0.0091）</span><strong><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(89, 87, 87);\">，餐后2小时血糖显著降低更多</span></strong><span style=\"color: rgb(136, 136, 136);font-family: 微软雅黑;font-size: 15px;\">（-5.45mmol/L vs -2.97mmol/L, , p&lt;0.0001）（图8）</span><strong><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(89, 87, 87);\">；</span></strong></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><strong><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(89, 87, 87);\"><br></span></strong></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><strong><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(89, 87, 87);\">显著改善β 细胞功能和胰岛素抵抗： 多扎格列艾汀治疗组HOMA2-β增加了3.77％，安慰剂对照组增加了1.35％； 多扎格列艾汀治疗组HOMA2-IR也较对照组明显改善；</span></strong></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><strong><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(89, 87, 87);\"><br></span></strong></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><strong><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(89, 87, 87);\">同时24周治疗期内，具有临床意义的低血糖</span></strong><span style=\"color: rgb(136, 136, 136);font-family: 微软雅黑;font-size: 15px;\">（血糖&lt;3mmol/L）</span><strong><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(89, 87, 87);\">发生率&lt;1%，未发生与药物相关的严重不良反应和严重低血糖事件。</span></strong></p></section></section></section></section></section></section></section></section></section></section><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><br></p><section style=\"text-align: justify;line-height: 1.75em;margin-left: 8px;margin-right: 8px;\"><img class=\"rich_pages\" data-ratio=\"0.4332129963898917\" data-s=\"300,640\" data-type=\"png\" data-w=\"554\" style=\"max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BluEe4v6gFxsvapLoqDlegmozlFmjuLicibD5L2ibQpXbMfxFHRaPgrm21g/640?wx_fmt=png\"></section><section style=\"text-align: justify;line-height: 1.75em;margin-left: 8px;margin-right: 8px;\"><span style=\"font-size: 12px;color: rgb(136, 136, 136);\"><span style=\"font-family: 微软雅黑;\">图6：与安慰剂相比，Dorzagliatin与二甲双胍联合治疗HbA</span><sub><span style=\"font-family: 微软雅黑;vertical-align: sub;\">1c</span></sub><span style=\"font-family: 微软雅黑;\">降幅显著更优</span></span></section><section style=\"text-align: justify;line-height: 1.75em;margin-left: 8px;margin-right: 8px;\"><br></section><section style=\"text-align: justify;line-height: 1.75em;margin-left: 8px;margin-right: 8px;\"><img class=\"rich_pages\" data-ratio=\"0.427797833935018\" data-s=\"300,640\" data-type=\"png\" data-w=\"554\" style=\"max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlUaoQyULnld2ogxo5WLXicmECa9e4s7sY2kOdRO3MynpWtjutwLXkKmQ/640?wx_fmt=png\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\"> </span></section><section style=\"text-align: justify;line-height: 1.75em;margin-left: 8px;margin-right: 8px;\"><span style=\"font-size: 12px;color: rgb(136, 136, 136);\"><span style=\"font-family: 微软雅黑;\">图7：与安慰剂相比，Dorzagliatin与二甲双胍联合治疗HbA</span><sub><span style=\"font-family: 微软雅黑;vertical-align: sub;\">1c</span></sub><span style=\"font-family: 微软雅黑;\">达标率显著更高</span></span></section><section style=\"text-align: justify;line-height: 1.75em;margin-left: 8px;margin-right: 8px;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\"> </span></section><section style=\"text-align: justify;line-height: 1.75em;margin-left: 8px;margin-right: 8px;\"><img class=\"rich_pages\" data-ratio=\"0.43501805054151627\" data-s=\"300,640\" data-type=\"png\" data-w=\"554\" style=\"max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlzqN3RJTZPMsCZ5mFhBAhuSQcHbSkEH7yJgAJyzZTKicTejibjxSfuX1g/640?wx_fmt=png\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\"> </span></section><section style=\"text-align: justify;line-height: 1.75em;margin-left: 8px;margin-right: 8px;\"><span style=\"font-size: 12px;color: rgb(136, 136, 136);font-family: 微软雅黑;\">图8：与安慰剂相比，Dorzagliatin与二甲双胍联合治疗空腹血糖与餐后血糖下降更显著</span></section><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">此外， 其他的联合治疗I期研究，也让我们看到多扎格列艾汀</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">良好的联用前景：</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><br></p><section><section data-tools=\"新媒体排版\" data-id=\"3237528\" data-style-type=\"undefined\"><section style=\"border-width: 0px;border-style: none;border-color: initial;max-width: 100%;\"><section powered-by=\".us\" style=\"box-sizing: border-box;max-width: 100%;\"><section style=\"margin-top: 0.5em;margin-bottom: 0.5em;padding-left: 0.45em;box-sizing: border-box;max-width: 100%;\"><section style=\"padding: 5px;box-sizing: border-box;max-width: 100%;border-left: 2px solid rgb(204, 204, 204);\"><section powered-by=\".us\" style=\"box-sizing: border-box;max-width: 100%;\"><section style=\"box-sizing: border-box;max-width: 100%;\"><section style=\"box-sizing: border-box;max-width: 100%;\"><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-family: 微软雅黑;font-size: 15px;\">多扎格列艾汀</span></strong><span style=\"font-family: 微软雅黑;font-size: 15px;\">（Dorzagliatin）</span><strong><span style=\"font-family: 微软雅黑;font-size: 15px;\">与DPP4抑制剂</span></strong><span style=\"font-family: 微软雅黑;font-size: 15px;\">（西格列汀）</span><strong><span style=\"font-family: 微软雅黑;font-size: 15px;\">或SGLT2抑制剂</span></strong><span style=\"font-family: 微软雅黑;font-size: 15px;\">（恩格列净）</span><strong><span style=\"font-family: 微软雅黑;font-size: 15px;\">联合治疗时，不影响各自的药代动力学参数；</span></strong></span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-family: 微软雅黑;font-size: 15px;\"><br></span></strong></span></p><section style=\"white-space: normal;\"><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">与单药相比，联合治疗降糖效果增加更明显；</span></strong></span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\"><br></span></strong></span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">多扎格列艾汀</span></strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">（Dorzagliatin）</span><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">与西格列汀联用后，半小时内GLP-1水平就较单用西格列汀明显增加；</span></strong></span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\"><br></span></strong></span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"color: rgb(89, 87, 87);\"><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">多扎格列艾汀</span></strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">（Dorzagliatin）</span><strong><span style=\"font-size: 15px;font-family: 微软雅黑;\">与恩格列净联用后，早相C-肽水平也明显升高。</span></strong></span></p></section></section></section></section></section></section></section></section></section></section><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;text-align: center;\"><span style=\"font-size: 17px;color: rgb(255, 255, 255);background-color: rgb(215, 0, 15);\"><strong><span style=\"background-color: rgb(215, 0, 15);font-family: 微软雅黑;\">  总结  </span></strong></span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);\"><strong><span style=\"font-family: 微软雅黑;\"><br></span></strong></span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;color: rgb(0, 0, 0);\"><span style=\"font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">作为维持人体血糖稳态的核心</span>“元件”<span style=\"font-family: 微软雅黑;\">，</span></span><span style=\"font-family: 等线;\"> </span><span style=\"font-family: 微软雅黑;\">葡萄糖激酶</span></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">的损伤是</span>T2DM<span style=\"font-family: 微软雅黑;\">患者血糖稳态失衡的重要</span>“推手”<span style=\"font-family: 微软雅黑;\">。在</span>T2DM<span style=\"font-family: 微软雅黑;\">的治疗中，需要恢复这个葡萄糖传感器功能，才能进一步优化血糖管理效果。全球首创的在研葡萄糖激酶双重激活剂多扎格列艾汀</span></span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">可作用于血糖调控的核心器官</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（胰岛和肝脏）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\">，具有修复葡萄糖激酶</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（GK）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">活性，提高对葡萄糖的敏感性，改善胰岛素早相分泌和葡萄糖的储备功能，重塑血糖稳态的潜力，旨在从源头上治疗糖尿病。两项</span>III期临床研究表明，多扎格列艾汀</span><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">单药或联合二甲双胍均有效降低</span>HbA</span><span style=\"color: rgb(0, 0, 0);font-size: 12px;\"><sub><span style=\"font-family: 微软雅黑;vertical-align: sub;\">1c</span></sub></span><span style=\"font-size: 15px;color: rgb(0, 0, 0);font-family: 微软雅黑;\"><span style=\"font-family: 微软雅黑;\">，显著改善胰岛</span>β细胞功能和胰岛素抵抗，耐受性和安全性良好，带来了治疗糖尿病的希望之光。</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">2020年8月17日，华领医药与拜耳集团就处于临床试验阶段的首创糖尿病治疗药物多扎格列艾汀</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(136, 136, 136);\">（Dorzagliatin）</span><span style=\"font-size: 15px;font-family: 微软雅黑;color: rgb(0, 0, 0);\">在中国达成商业合作协议，此项协议将发挥拜耳在中国糖尿病管理领域的领先优势以及华领医药的创新能力，为中国糖尿病患者提供全新的治疗方案选择。</span></p><p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 15px;color: rgb(0, 0, 0);\"> </span></p><section yne-bulb-block=\"paragraph\" style=\"max-width: 100%;font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal border-box break-word><section style=\"max-width: 100%;box-sizing: border-box;font-family: -apple-system-font, BlinkMacSystemFont, Arial, sans-serif;overflow-wrap: break-word !important;\"><section style=\"max-width: 100%;box-sizing: border-box;overflow-wrap: break-word !important;\"><section style=\"max-width: 100%;box-sizing: border-box;overflow-wrap: break-word !important;\"><section style=\"max-width: 100%;box-sizing: border-box;overflow-wrap: break-word !important;\"><section style=\"margin: 1em auto;max-width: 100%;box-sizing: border-box;overflow-wrap: break-word !important;\"><section style=\"margin-right: auto;margin-left: auto;padding: 1em;max-width: 100%;box-sizing: border-box;background: none 0% 0% / auto repeat scroll padding-box border-box rgb(240, 240, 240);height: 10em;line-height: 1.5em;overflow: auto;overflow-wrap: break-word !important;\"><section style=\"line-height: 1.75em;margin-left: 8px;margin-right: 8px;\"><span style=\"font-size: 12px;color: rgb(136, 136, 136);\"><strong>资料来源：</strong></span></section><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">1. Irwin DM, Tan H. Molecular evolution of the vertebrate hexokinase gene family: Identification of a conserved fifth vertebrate hexokinase gene[J]. Comp Biochem Physiol Part D Genomics Proteomics, 2008, 3(1):96-107.</span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">2. MatschinskyFM, WilsonDF. The central role of glucokinase in glucose homeostasis: a perspective 50 years after demonstrating the presence of the enzyme in islets of Langerhans[J]. Front Physiol, 2019, 10:148-163.</span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">3. Li C, Liu C, Nissim I, et al. Regulation of glucagon secretion in normal and diabetic human islets by γ-hydroxybutyrate and glycine[J]. J Biol Chem, 2013, 288(6):3938-51.</span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">4. Haeusler RA, Camastra S, Astiarraga B, et al. Decreased expression of hepatic glucokinase in type 2 diabetes[J]. Mol Metab. 2014, 4(3):222-6.</span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">5. Caro JF, Triester S, Patel VK, et al. Liver glucokinase: decreased activity in patients with type II diabetes[J]. Horm Metab Res, 1995, 27(1):19-22.</span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">6. Clore JN, Stillman J, Sugerman H. Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes[J]. Diabetes. 2000, 49(6):969-74.</span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">7. Grewal AS, Sekhon BS, Lather V. Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus[J]. Mini Rev Med Chem. 2014, 14(7):585-602.</span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">8. Li Chen, Y Zhang, et al. ADA 75th Scientific Session, June 5-9, 2015, Boston.</span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">9. Wang P, Liu H, Chen L, et al. Effects of a Novel Glucokinase Activator, HMS5552, on Glucose Metabolism in a Rat Model of Type 2 Diabetes Mellitus[J]. J Diabetes Res, 2017, 2017:5812607.</span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">10. Bergstrom RW, Wahl PW, Leonetti DL, Fujimoto WY. Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance[j]. J Clin Endocrinol Metab, 1990, 71(6):1447-53.</span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">11. DL Zhu, et al. ADA 75th Scientific Session, 2015, Boston.</span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">12. Zhu D, Gan S, Liu Y, et al. Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study[J]. Lancet Diabetes Endocrinol, 2018, 6(8):627-636.</span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">13. Hua Medicine for 2020 ADA Scientific Sessions.</span></p><p style=\"margin-right: 8px;margin-left: 8px;white-space: normal;line-height: 1.75em;\"><span style=\"font-family: 微软雅黑;font-size: 12px;color: rgb(136, 136, 136);\">14. RISE Consortium. Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes[J]. Diabetes Care, 2019, 42(9):1742-1751.</span></p></section></section></section></section></section></section><section style=\"max-width: 100%;text-align: center;clear: both;margin-left: 8px;margin-right: 8px;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><br></section><section data-role=\"outer\" label=\"Powered by 135editor.com\" style=\"max-width: 100%;letter-spacing: 0.544px;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><section data-tools=\"135编辑器\" data-id=\"90215\" data-color=\"#d7000f\" style=\"max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><section style=\"margin-right: 8px;margin-left: 8px;max-width: 100%;text-align: center;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><br></section></section></section></section><section><section><section style=\"margin-left: 8px;margin-right: 8px;\"><span style=\"font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif rgb>来源：医学界</span></section></section></section><section><section><section style=\"margin-left: 8px;margin-right: 8px;\"><span style=\"font-size: 12px;color: rgb(136, 136, 136);\">校对：臧恒佳<br style=\"max-width: 100%;box-sizing: border-box;overflow-wrap: break-word !important;\"></span></section></section></section><section><section><section style=\"margin-left: 8px;margin-right: 8px;\"><span style=\"font-size: 12px;color: rgb(136, 136, 136);\">责编：潘颖</span></section></section></section><section data-role=\"outer\" label=\"Powered by 135editor.com\" style=\"max-width: 100%;font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal border-box break-word><section data-tools=\"135编辑器\" data-id=\"90215\" data-color=\"#d7000f\" style=\"max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><section data-role=\"outer\" label=\"Powered by 135editor.com\" style=\"font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal border-box break-word><section data-tools=\"135编辑器\" data-id=\"90215\" data-color=\"#d7000f\" style=\"max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><section style=\"margin-right: 8px;margin-left: 8px;max-width: 100%;text-align: center;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><span style=\"max-width: 100%;color: rgb(0, 0, 0);box-sizing: border-box !important;overflow-wrap: break-word !important;\"><strong style=\"max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><span style=\"max-width: 100%;font-size: 15px;box-sizing: border-box !important;overflow-wrap: break-word !important;\">往期</span></strong></span><span style=\"max-width: 100%;color: rgb(215, 0, 15);box-sizing: border-box !important;overflow-wrap: break-word !important;\"><strong style=\"max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><span style=\"max-width: 100%;font-size: 15px;box-sizing: border-box !important;overflow-wrap: break-word !important;\">精彩</span></strong></span><span style=\"max-width: 100%;color: rgb(0, 0, 0);box-sizing: border-box !important;overflow-wrap: break-word !important;\"><strong style=\"max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><span style=\"max-width: 100%;font-size: 15px;box-sizing: border-box !important;overflow-wrap: break-word !important;\">回顾</span></strong></span></section><section style=\"margin-right: 8px;margin-left: 8px;max-width: 100%;line-height: 1.5em;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><section style=\"margin-top: 10px;max-width: 100%;display: flex;justify-content: center;align-items: center;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><section data-width=\"100%\" style=\"margin-top: -20px;max-width: 100%;width: 317.5px;border-bottom: 1px solid rgb(114, 114, 114);height: 1px;overflow: hidden;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><br style=\"max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\"></section><section style=\"margin-right: auto;margin-left: auto;padding-right: 5px;padding-left: 5px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><section style=\"margin-top: -2px;margin-right: auto;margin-left: auto;max-width: 100%;height: 16px;width: 0px;border-width: 8px;border-style: solid;border-color: rgb(215, 0, 15) transparent transparent;overflow: hidden;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><br style=\"max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\"></section><section data-bdless=\"spin\" data-bdlessp=\"280\" data-bdopacity=\"50%\" style=\"margin-top: -7px;margin-right: auto;margin-left: auto;max-width: 100%;height: 12px;width: 0px;border-width: 6px;border-style: solid;border-color: rgba(215, 0, 15, 0.498) transparent transparent;overflow: hidden;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><br style=\"max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\"></section></section><section data-width=\"100%\" style=\"margin-top: -20px;max-width: 100%;width: 317.5px;border-bottom: 1px solid rgb(114, 114, 114);height: 1px;overflow: hidden;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><br style=\"max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\"></section></section><a target=\"_blank\" href=\"http://mp.weixin.qq.com/s?__biz=MjM5MDc3NjQwMA==&amp;mid=2926678202&amp;idx=1&amp;sn=44b66640e3343dd054f3d6b4ab837ecb&amp;chksm=8d3a9d85ba4d1493a1df0e80d546e525a7fff040ef3699ffc405d842f7376dc80dd69789ac78&amp;scene=21#wechat_redirect\" data-itemshowtype=\"0\" tab=\"innerlink\" data-linktype=\"2\" style=\"font-size: 14px;\"><span style=\"font-size: 14px;\">中国终于要有自己首创的糖尿病药物了！原来它经历了这么多……</span></a></section><section style=\"margin-right: 8px;margin-left: 8px;max-width: 100%;line-height: 1.5em;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><a target=\"_blank\" href=\"http://mp.weixin.qq.com/s?__biz=MjM5MDc3NjQwMA==&amp;mid=2926678372&amp;idx=1&amp;sn=3f555ba006ba03c8d65c427acd64ec42&amp;chksm=8d3a9c5bba4d154d6fa88c060e01cd44d5b9b2c2dc1cf7b6fa53d2abb26a0d9229fd496109b4&amp;scene=21#wechat_redirect\" data-itemshowtype=\"0\" tab=\"innerlink\" data-linktype=\"2\" style=\"font-size: 14px;\"><span style=\"font-size: 14px;\">直击CDS重磅，朱大龙教授高亮点评这款全球首创药物研究进展！</span></a><br></section><section style=\"margin-right: 8px;margin-left: 8px;max-width: 100%;line-height: 1.5em;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><a target=\"_blank\" href=\"http://mp.weixin.qq.com/s?__biz=MzUxNzY3MDg4NQ==&amp;mid=2247504110&amp;idx=1&amp;sn=aedee9d5655a9619732dff9ba0709cd4&amp;chksm=f9960264cee18b72910d90eeaa2182b01ba1ff467b4db5f4d5f57181e4fae1e308b6eb8a82bb&amp;scene=21#wechat_redirect\" data-itemshowtype=\"0\" tab=\"innerlink\" style=\"font-size: 14px;\" data-linktype=\"2\"><span style=\"font-size: 14px;\">重磅！历史的跨越，中国糖尿病全球首创新药III期研究来了！| CDS 2019</span></a><br></section><section style=\"margin-top: 10px;margin-right: 8px;margin-left: 8px;max-width: 100%;width: 677px;border-bottom: 1px solid rgb(114, 114, 114);height: 1px;overflow: hidden;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><br style=\"max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\"></section></section></section><section style=\"max-width: 100%;text-align: center;width: 677px;font-size: 16px;color: rgb(114, 114, 114);letter-spacing: 2px;font-weight: bold;margin-left: 8px;margin-right: 8px;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><br></section></section></section><section data-role=\"paragraph\" style=\"max-width: 100%;font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif normal border-box break-word><section style=\"text-align: center;margin-left: 8px;margin-right: 8px;\"><img class=\"rich_pages js_insertlocalimg\" data-ratio=\"0.5555555555555556\" data-s=\"300,640\" data-type=\"png\" data-w=\"900\" style=\"max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyorS4PggDpXqpicD8J3D30x0qFwia8SITjagF67QNQiaYEUHj2a6Io5ibCrPuL3iap0USaicOibeCESbdeG5A/640?wx_fmt=png\"></section></section></section><section style=\"white-space: normal;max-width: 100%;font-family: -apple-system-font, BlinkMacSystemFont, \" helvetica neue sc sans gb yahei ui arial sans-serif rgb border-box break-word><section style=\"max-width: 100%;letter-spacing: 0.544px;display: inline-block;width: 30px;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><p style=\"margin-right: 8px;margin-left: 8px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><img class=\"__bg_gif\" data-ratio=\"1\" data-type=\"gif\" data-w=\"400\" style=\"display: inline-block; vertical-align: middle; box-sizing: border-box !important; overflow-wrap: break-word !important; visibility: visible !important; width: 400px !important; max-width: 600px\" src=\"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/a1xwNbPmyorVMjtSHeT1D116ticxWpGsvo7D8UTuo2WQvPhG1JP7QszTVqJwwZux2Ab8yZ5Dbib2lf6PrnBic2b0g/640?wx_fmt=gif\"><span style=\"max-width: 100%;font-size: 12px;box-sizing: border-box !important;overflow-wrap: break-word !important;\"></span></p></section><section data-brushtype=\"text\" style=\"margin-left: 5px;max-width: 100%;letter-spacing: 0.544px;display: inline-block;vertical-align: middle;font-size: 12px;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><p style=\"margin-right: 8px;margin-left: 8px;max-width: 100%;min-height: 1em;box-sizing: border-box !important;overflow-wrap: break-word !important;\"><span style=\"max-width: 100%;text-align: right;font-family: mp-quote, -apple-system-font, BlinkMacSystemFont, Arial, sans-serif;box-sizing: border-box !important;overflow-wrap: break-word !important;\">点击“<strong style=\"max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">阅读原文</strong>”，查看更多资讯~        </span></p></section></section>\n                </div>\n\n    \n        <br>\n        <div id=\"js_toobar3\" class=\"rich_media_tool\">\n            <a target=\"_blank\" href=\"https://merch.yishengzhan.cn/gkxy/#/\" id=\"js_view_source\" class=\"media_tool_meta meta_primary\">阅读原文</a>\n        </div>\n    \n    <br>\n\n    \n        <a target=\"_blank\" href=\"http://mp.weixin.qq.com/s?__biz=MjM5MDc3NjQwMA==&amp;mid=2926704690&amp;idx=1&amp;sn=6af88b23ebc833bdcb4e774b8667d1fe&amp;chksm=8d3af50dba4d7c1bec04643acc6358fa4ddcecb7735058001884f38addf8229fd0e2db707714&amp;scene=0#rd\" style=\"color: blue\" class=\"media_tool_meta meta_primary\">原文</a>\n        <br>\n    \n\n    \n\n    <img alt=\"\" width=\"1px\" height=\"1px\" class=\"\" style=\"width:1px;height:1px;display:none\" src=\"http://www.jintiankansha.me/rss_static/20145/N4u6Au7mdR\"></div></div>","descriptionType":"html","publishedDate":"Tue, 01 Dec 2020 13:01:00 +0000","feedId":1661,"bgimg":"http://content.sov5.cn/mmbiz_jpg/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5Bl2Bz54uAEVJLTE3lMQars1EoicC160Golb7djklWKAJbuoTDnKDnNRlw?imageView2/1/w/600","linkMd5":"0e30d260f95cb97be28a348352274be9","bgimgJsdelivr":"https://cdn.jsdelivr.net/gh/myreaderx10/cdn29@2020_3/2020/12/03/02-53-05-263_affb26159b0bce6e.webp","destWidth":600,"destHeight":351,"sourceBytes":30663,"destBytes":26542,"author":"","articleImgCdnMap":{"http://content.sov5.cn/mmbiz_jpg/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5Bl2Bz54uAEVJLTE3lMQars1EoicC160Golb7djklWKAJbuoTDnKDnNRlw?imageView2/1/w/600":"https://cdn.jsdelivr.net/gh/myreaderx10/cdn29@2020_3/2020/12/03/02-53-05-263_affb26159b0bce6e.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyorS4PggDpXqpicD8J3D30x0qz8wxx0IxiaV6ddh7j6PABXqreL16wWiciaktlibvT60APRvH8Ob72XtplA/640?wx_fmt=png":"https://cdn.jsdelivr.net/gh/myreaderx2/cdn69@2020_5/2020/12/03/02-53-14-849_24f2a13e816f26f1.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5Blpw09CLangxEgy1VAKtFjrPS0lf58xOqU6zMCV7O7Bb6XZ7Dv13p1Hw/640?wx_fmt=png":"https://cdn.jsdelivr.net/gh/myreaderx/cdn43@2020_1/2020/12/03/02-55-32-852_923a8ce50bd7f2ea.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5Bl1EctiaYIhW4JQ2JicKQjHGsPuLKpAyzAvocMP0lgH9OIWcwetqAog4Bg/640?wx_fmt=png":"https://cdn.jsdelivr.net/gh/myreaderx30/cdn59@2020_1/2020/12/03/02-53-20-832_3cc3d658b5f7a0bc.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlH3bibA8lljbCYwlTmQfZ8wQhZDuUl3Yt3ReKnJKP1O3b9RPSzulf7Pg/640?wx_fmt=png":null,"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5Bl7khCodmvt9fmXRcialXibUIFNvPaJNHtzrDDicefRkezpcXic0QCcp7aog/640?wx_fmt=png":"https://cdn.jsdelivr.net/gh/myreaderx19/cdn36@2020_4/2020/12/03/02-53-09-054_685d3196bcb65a2f.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlPRvA3j8urjnfS4pZ97JtBjUwAibJjYQRH7jVxB9iaXn0QNkM25zbvLXw/640?wx_fmt=png":"https://cdn.jsdelivr.net/gh/myreaderx4/cdn65@2020_3/2020/12/03/02-53-17-576_de29f434058a225e.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlmXx4kJFWxKEj04RKa8S6EKptNH2icfngcWhwS7rHBiaeD2JOKCWXsIiaQ/640?wx_fmt=png":"https://cdn.jsdelivr.net/gh/myreaderx15/cdn49@2020_6/2020/12/03/02-53-21-761_366e3880b934f8a8.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BluEe4v6gFxsvapLoqDlegmozlFmjuLicibD5L2ibQpXbMfxFHRaPgrm21g/640?wx_fmt=png":"https://cdn.jsdelivr.net/gh/myreaderx25/cdn40@2020_3/2020/12/03/02-53-11-506_42bb08d8276609f3.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlUaoQyULnld2ogxo5WLXicmECa9e4s7sY2kOdRO3MynpWtjutwLXkKmQ/640?wx_fmt=png":"https://cdn.jsdelivr.net/gh/myreaderx27/cdn54@2020_1/2020/12/03/02-53-26-408_c9e6c216d38b858f.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlzqN3RJTZPMsCZ5mFhBAhuSQcHbSkEH7yJgAJyzZTKicTejibjxSfuX1g/640?wx_fmt=png":"https://cdn.jsdelivr.net/gh/myreaderx33/cdn58@2020_2/2020/12/03/02-53-20-583_fc45f01094204c01.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyorS4PggDpXqpicD8J3D30x0qFwia8SITjagF67QNQiaYEUHj2a6Io5ibCrPuL3iap0USaicOibeCESbdeG5A/640?wx_fmt=png":"https://cdn.jsdelivr.net/gh/myreaderx31/cdn81@2020_2/2020/12/03/02-53-20-971_5d4f2f6f7a21ec59.webp","http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/a1xwNbPmyorVMjtSHeT1D116ticxWpGsvo7D8UTuo2WQvPhG1JP7QszTVqJwwZux2Ab8yZ5Dbib2lf6PrnBic2b0g/640?wx_fmt=gif":"https://cdn.jsdelivr.net/gh/myreaderx29/cdn77@2020_5/2020/12/03/02-53-12-301_043b590fe087ce48.webp","http://www.jintiankansha.me/rss_static/20145/N4u6Au7mdR":null},"publishedOrCreatedDate":1606963984439}],"record":{"createdTime":"2020-12-03 10:53:04","updatedTime":"2020-12-03 10:53:04","feedId":1661,"fetchDate":"Thu, 03 Dec 2020 02:53:04 +0000","fetchMs":225,"handleMs":60,"totalMs":150875,"newArticles":0,"totalArticles":5,"status":1,"type":0,"ip":"649c417ce44ee5dd84e136a61274e5e4","hostName":"us-015*","requestId":"ce0d7075a7b14d2b96be12cb14fb4db1_1661","contentType":"application/rss+xml","totalBytes":291196,"bgimgsTotal":1,"bgimgsGithubTotal":1,"articlesImgsTotal":14,"articlesImgsGithubTotal":12,"successGithubMap":{"myreaderx25":1,"myreaderx15":1,"myreaderx27":1,"myreaderx10":1,"myreaderx4":1,"myreaderx33":1,"myreaderx2":1,"myreaderx30":1,"myreaderx31":1,"myreaderx29":1,"myreaderx19":1,"myreaderx":1},"failGithubMap":{"myreaderx14":1}},"feed":{"createdTime":"2020-08-24 21:31:31","updatedTime":"2020-09-01 09:50:49","id":1661,"name":"医学界","url":"http://feedmaker.kindle4rss.com/feeds/yixuejiezazhi.weixin.xml","subscriber":null,"website":null,"icon":"http://www.sogou.com/images/logo/new/favicon.ico?v=4","icon_jsdelivr":"https://cdn.jsdelivr.net/gh/myreaderx61/cdn75@2020_6/2020/09/01/01-50-49-815_d24121c9beed1de6.ico","description":"《医学界》以有品位、有追求、有爱心、有水平的医务工作者为受众，以“服务医生，改善医疗”为宗旨，让行医更幸福是我们的使命，为用户提供可靠、有用、有价值观的资讯是我们的存在方式。","weekly":null,"link":null},"noPictureArticleList":[{"createdTime":"2020-12-03 10:55:34","updatedTime":"2020-12-03 10:55:34","id":null,"feedId":1661,"linkMd5":"0e30d260f95cb97be28a348352274be9"}],"tmpCommonImgCdnBytes":26542,"tmpBodyImgCdnBytes":264654,"tmpBgImgCdnBytes":0,"extra4":{"start":1606963984049,"total":0,"statList":[{"spend":333,"msg":"获取xml内容"},{"spend":60,"msg":"解释文章"},{"spend":0,"msg":"上传封面图到cdn"},{"spend":1,"msg":"修正封面图上传失败重新上传"},{"spend":147619,"msg":"正文链接上传到cdn"}]},"extra5":14,"extra6":14,"extra7ImgCdnFailResultVector":[{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlH3bibA8lljbCYwlTmQfZ8wQhZDuUl3Yt3ReKnJKP1O3b9RPSzulf7Pg/640?wx_fmt=png","sourceStatusCode":403,"sourceBytes":0,"destBytes":0,"feedId":1661,"totalSpendMs":1046,"convertSpendMs":0,"createdTime":"2020-12-03 10:53:07","host":"us-028*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","extra22GetBytesInfo":"2、Referer字段 ： http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","extra23historyStatusCode":[403,403],"sourceSize":"0","destSize":"0"},{"code":1,"isDone":false,"source":"http://www.jintiankansha.me/rss_static/20145/N4u6Au7mdR","sourceStatusCode":405,"sourceBytes":0,"destBytes":0,"feedId":1661,"totalSpendMs":1057,"convertSpendMs":0,"createdTime":"2020-12-03 10:53:07","host":"us-006*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[405],"sourceSize":"0","destSize":"0"},{"code":1,"isDone":false,"source":"http://www.jintiankansha.me/rss_static/20145/N4u6Au7mdR","sourceStatusCode":405,"sourceBytes":0,"destBytes":0,"feedId":1661,"totalSpendMs":821,"convertSpendMs":0,"createdTime":"2020-12-03 10:53:08","host":"europe68*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[405],"sourceSize":"0","destSize":"0"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlH3bibA8lljbCYwlTmQfZ8wQhZDuUl3Yt3ReKnJKP1O3b9RPSzulf7Pg/640?wx_fmt=png","sourceStatusCode":200,"destWidth":554,"destHeight":214,"sourceBytes":66271,"destBytes":16206,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":24836,"convertSpendMs":11,"createdTime":"2020-12-03 10:53:08","host":"europe-22*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","rawMap":{"githubUrl":"https://api.github.com/repos/myreaderx14/cdn73/contents/2020/12/03/02-53-33-097_1096e0529bd8bb55.webp","resp":{"code":403,"msg":"Forbidden","body":"{\n  \"message\": \"API rate limit exceeded for user ID 68584859.\",\n  \"documentation_url\": \"https://docs.github.com/rest/overview/resources-in-the-rest-api#rate-limiting\"\n}\n","headerMap":{"access-control-allow-origin":["*"],"access-control-expose-headers":["ETag, Link, Location, Retry-After, X-GitHub-OTP, X-RateLimit-Limit, X-RateLimit-Remaining, X-RateLimit-Used, X-RateLimit-Reset, X-OAuth-Scopes, X-Accepted-OAuth-Scopes, X-Poll-Interval, X-GitHub-Media-Type, Deprecation, Sunset"],"content-security-policy":["default-src 'none'"],"content-type":["application/json; charset=utf-8"],"date":["Thu, 03 Dec 2020 02:53:33 GMT"],"referrer-policy":["origin-when-cross-origin, strict-origin-when-cross-origin"],"server":["GitHub.com"],"status":["403 Forbidden"],"strict-transport-security":["max-age=31536000; includeSubdomains; preload"],"transfer-encoding":["chunked"],"vary":["Accept-Encoding, Accept, X-Requested-With"],"x-accepted-oauth-scopes":["repo"],"x-content-type-options":["nosniff"],"x-frame-options":["deny"],"x-github-media-type":["github.v3; format=json"],"x-github-request-id":["9024:23E6:C31405:E05039:5FC8532D"],"x-oauth-scopes":["admin:enterprise, admin:gpg_key, admin:org, admin:org_hook, admin:public_key, admin:repo_hook, delete:packages, delete_repo, gist, notifications, repo, user, workflow, write:discussion, write:packages"],"x-ratelimit-limit":["60"],"x-ratelimit-remaining":["0"],"x-ratelimit-reset":["1606967304"],"x-ratelimit-used":["60"],"x-xss-protection":["1; mode=block"]},"exceptionMsg":"Unexpected code 403,url is : https://api.github.com/repos/myreaderx14/cdn73/contents/2020/12/03/02-53-33-097_1096e0529bd8bb55.webp","historyStatusCode":[],"spendMs":273},"base64UserPassword":null,"token":"6b67d******************************91b08"},"githubUser":"myreaderx14","githubHttpCode":403,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"64.7 KB","destSize":"15.8 KB","compressRate":"24.5%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlH3bibA8lljbCYwlTmQfZ8wQhZDuUl3Yt3ReKnJKP1O3b9RPSzulf7Pg/640?wx_fmt=png","sourceStatusCode":200,"destWidth":554,"destHeight":214,"sourceBytes":66271,"destBytes":16206,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":12911,"convertSpendMs":32,"createdTime":"2020-12-03 10:53:33","host":"us-016*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","rawMap":{"githubUrl":"https://api.github.com/repos/myreaderx14/cdn73/contents/2020/12/03/02-53-46-257_1096e0529bd8bb55.webp","resp":{"code":403,"msg":"Forbidden","body":"{\n  \"message\": \"API rate limit exceeded for user ID 68584859.\",\n  \"documentation_url\": \"https://docs.github.com/rest/overview/resources-in-the-rest-api#rate-limiting\"\n}\n","headerMap":{"access-control-allow-origin":["*"],"access-control-expose-headers":["ETag, Link, Location, Retry-After, X-GitHub-OTP, X-RateLimit-Limit, X-RateLimit-Remaining, X-RateLimit-Used, X-RateLimit-Reset, X-OAuth-Scopes, X-Accepted-OAuth-Scopes, X-Poll-Interval, X-GitHub-Media-Type, Deprecation, Sunset"],"content-security-policy":["default-src 'none'"],"content-type":["application/json; charset=utf-8"],"date":["Thu, 03 Dec 2020 02:53:46 GMT"],"referrer-policy":["origin-when-cross-origin, strict-origin-when-cross-origin"],"server":["GitHub.com"],"status":["403 Forbidden"],"strict-transport-security":["max-age=31536000; includeSubdomains; preload"],"transfer-encoding":["chunked"],"vary":["Accept-Encoding, Accept, X-Requested-With"],"x-accepted-oauth-scopes":["repo"],"x-content-type-options":["nosniff"],"x-frame-options":["deny"],"x-github-media-type":["github.v3; format=json"],"x-github-request-id":["B052:452D:1DCCD:5BB83:5FC85338"],"x-oauth-scopes":["admin:enterprise, admin:gpg_key, admin:org, admin:org_hook, admin:public_key, admin:repo_hook, delete:packages, delete_repo, gist, notifications, repo, user, workflow, write:discussion, write:packages"],"x-ratelimit-limit":["60"],"x-ratelimit-remaining":["0"],"x-ratelimit-reset":["1606967304"],"x-ratelimit-used":["60"],"x-xss-protection":["1; mode=block"]},"exceptionMsg":"Unexpected code 403,url is : https://api.github.com/repos/myreaderx14/cdn73/contents/2020/12/03/02-53-46-257_1096e0529bd8bb55.webp","historyStatusCode":[],"spendMs":66},"base64UserPassword":null,"token":"6b67d******************************91b08"},"githubUser":"myreaderx14","githubHttpCode":403,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"64.7 KB","destSize":"15.8 KB","compressRate":"24.5%"},null],"extra10_invalidATagHrefValue":{},"extra111_proxyServerAndStatMap":{"http://europe-24.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]},"http://europe68.herokuapp.com/":{"failCount":1,"successCount":0,"resultList":[405]},"http://europe-58.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]},"http://us-028.herokuapp.com/":{"failCount":1,"successCount":0,"resultList":[403]},"http://us-024.herokuapp.com/":{"failCount":0,"successCount":2,"resultList":[200,200]},"http://us-006.herokuapp.com/":{"failCount":1,"successCount":0,"resultList":[405]},"http://europe-23.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]},"http://europe69.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]},"http://europe62.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]},"http://us-036.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]},"http://europe-57.herokuapp.com/":{"failCount":1,"successCount":0,"resultList":[null]},"http://us-003.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]},"http://europe-22.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]},"http://us-016.herokuapp.com/":{"failCount":0,"successCount":2,"resultList":[200,200]},"http://us-040.herokuapp.com/":{"failCount":0,"successCount":1,"resultList":[200]}},"extra12ImgCdnSuccessResultVector":[{"code":1,"isDone":false,"source":"http://content.sov5.cn/mmbiz_jpg/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5Bl2Bz54uAEVJLTE3lMQars1EoicC160Golb7djklWKAJbuoTDnKDnNRlw?imageView2/1/w/600","sourceStatusCode":200,"destWidth":600,"destHeight":351,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx10/cdn29@2020_3/2020/12/03/02-53-05-263_affb26159b0bce6e.webp","sourceBytes":30663,"destBytes":26542,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":1580,"convertSpendMs":21,"createdTime":"2020-12-03 10:53:04","host":"us-032*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9,0e30d260f95cb97be28a348352274be9","githubUser":"myreaderx10","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"29.9 KB","destSize":"25.9 KB","compressRate":"86.6%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5Bl7khCodmvt9fmXRcialXibUIFNvPaJNHtzrDDicefRkezpcXic0QCcp7aog/640?wx_fmt=png","sourceStatusCode":200,"destWidth":554,"destHeight":267,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx19/cdn36@2020_4/2020/12/03/02-53-09-054_685d3196bcb65a2f.webp","sourceBytes":52915,"destBytes":14682,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":2690,"convertSpendMs":13,"createdTime":"2020-12-03 10:53:07","host":"europe-58*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","githubUser":"myreaderx19","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"51.7 KB","destSize":"14.3 KB","compressRate":"27.7%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BluEe4v6gFxsvapLoqDlegmozlFmjuLicibD5L2ibQpXbMfxFHRaPgrm21g/640?wx_fmt=png","sourceStatusCode":200,"destWidth":554,"destHeight":240,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx25/cdn40@2020_3/2020/12/03/02-53-11-506_42bb08d8276609f3.webp","sourceBytes":50183,"destBytes":14456,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":5059,"convertSpendMs":11,"createdTime":"2020-12-03 10:53:07","host":"europe69*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","githubUser":"myreaderx25","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"49 KB","destSize":"14.1 KB","compressRate":"28.8%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_gif/a1xwNbPmyorVMjtSHeT1D116ticxWpGsvo7D8UTuo2WQvPhG1JP7QszTVqJwwZux2Ab8yZ5Dbib2lf6PrnBic2b0g/640?wx_fmt=gif","sourceStatusCode":200,"destWidth":400,"destHeight":400,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx29/cdn77@2020_5/2020/12/03/02-53-12-301_043b590fe087ce48.webp","sourceBytes":18415,"destBytes":23514,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":6005,"convertSpendMs":613,"createdTime":"2020-12-03 10:53:07","host":"us-016*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","githubUser":"myreaderx29","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"18 KB","destSize":"23 KB","compressRate":"127.7%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyorS4PggDpXqpicD8J3D30x0qz8wxx0IxiaV6ddh7j6PABXqreL16wWiciaktlibvT60APRvH8Ob72XtplA/640?wx_fmt=png","sourceStatusCode":200,"destWidth":900,"destHeight":300,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx2/cdn69@2020_5/2020/12/03/02-53-14-849_24f2a13e816f26f1.webp","sourceBytes":94158,"destBytes":28036,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":8369,"convertSpendMs":22,"createdTime":"2020-12-03 10:53:07","host":"us-040*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","githubUser":"myreaderx2","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"92 KB","destSize":"27.4 KB","compressRate":"29.8%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlPRvA3j8urjnfS4pZ97JtBjUwAibJjYQRH7jVxB9iaXn0QNkM25zbvLXw/640?wx_fmt=png","sourceStatusCode":200,"destWidth":554,"destHeight":328,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx4/cdn65@2020_3/2020/12/03/02-53-17-576_de29f434058a225e.webp","sourceBytes":33387,"destBytes":9920,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":11384,"convertSpendMs":10,"createdTime":"2020-12-03 10:53:07","host":"europe62*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","githubUser":"myreaderx4","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"32.6 KB","destSize":"9.7 KB","compressRate":"29.7%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlzqN3RJTZPMsCZ5mFhBAhuSQcHbSkEH7yJgAJyzZTKicTejibjxSfuX1g/640?wx_fmt=png","sourceStatusCode":200,"destWidth":554,"destHeight":241,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx33/cdn58@2020_2/2020/12/03/02-53-20-583_fc45f01094204c01.webp","sourceBytes":65877,"destBytes":17518,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":14155,"convertSpendMs":12,"createdTime":"2020-12-03 10:53:07","host":"europe-23*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","githubUser":"myreaderx33","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"64.3 KB","destSize":"17.1 KB","compressRate":"26.6%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5Bl1EctiaYIhW4JQ2JicKQjHGsPuLKpAyzAvocMP0lgH9OIWcwetqAog4Bg/640?wx_fmt=png","sourceStatusCode":200,"destWidth":554,"destHeight":213,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx30/cdn59@2020_1/2020/12/03/02-53-20-832_3cc3d658b5f7a0bc.webp","sourceBytes":84949,"destBytes":19184,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":14414,"convertSpendMs":9,"createdTime":"2020-12-03 10:53:07","host":"europe-24*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","githubUser":"myreaderx30","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"83 KB","destSize":"18.7 KB","compressRate":"22.6%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyorS4PggDpXqpicD8J3D30x0qFwia8SITjagF67QNQiaYEUHj2a6Io5ibCrPuL3iap0USaicOibeCESbdeG5A/640?wx_fmt=png","sourceStatusCode":200,"destWidth":900,"destHeight":500,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx31/cdn81@2020_2/2020/12/03/02-53-20-971_5d4f2f6f7a21ec59.webp","sourceBytes":146314,"destBytes":39658,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":14599,"convertSpendMs":50,"createdTime":"2020-12-03 10:53:07","host":"us-003*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","githubUser":"myreaderx31","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"142.9 KB","destSize":"38.7 KB","compressRate":"27.1%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlmXx4kJFWxKEj04RKa8S6EKptNH2icfngcWhwS7rHBiaeD2JOKCWXsIiaQ/640?wx_fmt=png","sourceStatusCode":200,"destWidth":554,"destHeight":266,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx15/cdn49@2020_6/2020/12/03/02-53-21-761_366e3880b934f8a8.webp","sourceBytes":48095,"destBytes":13804,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":15286,"convertSpendMs":10,"createdTime":"2020-12-03 10:53:07","host":"us-036*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","githubUser":"myreaderx15","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"47 KB","destSize":"13.5 KB","compressRate":"28.7%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5BlUaoQyULnld2ogxo5WLXicmECa9e4s7sY2kOdRO3MynpWtjutwLXkKmQ/640?wx_fmt=png","sourceStatusCode":200,"destWidth":554,"destHeight":237,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx27/cdn54@2020_1/2020/12/03/02-53-26-408_c9e6c216d38b858f.webp","sourceBytes":70963,"destBytes":19802,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":19912,"convertSpendMs":11,"createdTime":"2020-12-03 10:53:07","host":"us-024*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","githubUser":"myreaderx27","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"69.3 KB","destSize":"19.3 KB","compressRate":"27.9%"},{"code":1,"isDone":false,"source":"http://img2.jintiankansha.me/get?src=http://mmbiz.qpic.cn/mmbiz_png/a1xwNbPmyoosuo5WY4kLS5JVxicSqH5Blpw09CLangxEgy1VAKtFjrPS0lf58xOqU6zMCV7O7Bb6XZ7Dv13p1Hw/640?wx_fmt=png","sourceStatusCode":200,"destWidth":800,"destHeight":532,"fixedGithubDest":"https://cdn.jsdelivr.net/gh/myreaderx/cdn43@2020_1/2020/12/03/02-55-32-852_923a8ce50bd7f2ea.webp","sourceBytes":464674,"destBytes":64080,"targetWebpQuality":75,"feedId":1661,"totalSpendMs":55015,"convertSpendMs":29,"createdTime":"2020-12-03 10:54:38","host":"us-024*","referer":"http://weixin.sogou.com/weixin?type=2&query=%E5%8C%BB%E5%AD%A6%E7%95%8C+%E2%80%9C%E4%BF%AE%E5%A4%8D%E2%80%9D%E4%BA%BA%E4%BD%93%E8%91%A1%E8%90%84%E7%B3%96%E4%BC%A0%E6%84%9F%E5%99%A8%EF%BC%9A%E6%92%AD%E7%A7%8D%E7%B3%96%E5%B0%BF%E7%97%85%E6%B2%BB%E7%96%97%E7%9A%84%E6%96%B0%E5%B8%8C%E6%9C%9B%EF%BC%81","linkMd5ListStr":"0e30d260f95cb97be28a348352274be9","githubUser":"myreaderx","githubHttpCode":201,"extra22GetBytesInfo":"1、没有Referer字段","extra23historyStatusCode":[200],"sourceSize":"453.8 KB","destSize":"62.6 KB","compressRate":"13.8%"}],"successGithubMap":{"myreaderx25":1,"myreaderx15":1,"myreaderx27":1,"myreaderx10":1,"myreaderx4":1,"myreaderx33":1,"myreaderx2":1,"myreaderx30":1,"myreaderx31":1,"myreaderx29":1,"myreaderx19":1,"myreaderx":1},"failGithubMap":{"myreaderx14":1}}